Clinical Trial Update: E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating E7050 plus cisplatin and capecitabine versus cisplatin and capecitabine in patients with advanced or metastatic solid tumors, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• E7050

Snippet

Sponsor: Eisai Inc. | Conditions: Advanced or Metastatic Solid Tumors, Previously Untreated Gastric Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-03-13